Facebook Twitter YouTube Google Plus

Why is clinical trial participation important in mesothelioma?

Clinical trial participation is the life blood of progress in treating mesothelioma. When over 450 patietns world wide volunteered we were able to show that the 2 drug regimen of cisplatin and alimta was superior to cisplatin. That 2003 study estab lished that 2 drug regimen as the standard of care. However, we have since been unable to make much progress, in part because many patients and doctors prefer a “tried and true” approach. However the “tried and true” of using a 2 drug regimen does not advance the field. Mesothelioma patients need to be bold. They and their physicians need to push the boundaries and invest in the future by joining and demanding that clinical trials be available. If need be patients should travel to sites that have such trials available.

--Nicholas J. Vogelzang, MD, US Oncology Research

What do you hope to achieve as the new SAB Chair?

Why is clinical trial participation important in mesothelioma?

How does a pathologist diagnose mesothelioma?

Why is a second opinion important in mesothelioma?

My doctor told me that chemotherapy doesn’t work in mesothelioma. Is this true?

What advances have you seen over the years in gene therapy for mesothelioma?

What is new in your approach to treating peritoneal mesothelioma?

Is radiation therapy effective for pain control for patients with mesothelioma?

Can you tell me about the potential benefit of IMRT in mesothelioma?